Literature DB >> 1493979

2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa.

Z A Machan1, G W Taylor, T L Pitt, P J Cole, R Wilson.   

Abstract

Clinical isolates of Pseudomonas aeruginosa produce low molecular weight, hydrophobic substances which inhibit the growth of Staphylococcus aureus and other Gram-positive organisms. The active substances have been purified from a culture of P. aeruginosa and characterized as a mixture of 2-heptyl-4-hydroxyquinoline N-oxide and its homologues. The alkyl-hydroxyquinolines (derived through reduction of the N-oxide) were also produced by P. aeruginosa cultures but, in general, were less active against S. aureus. 2-Heptyl-4-hydroxyquinoline was identified in a sample of human bronchial secretions from a patient with cystic fibrosis who was heavily colonized with P. aeruginosa. Production of antibacterial alkyl-hydroxyquinoline N-oxides in human lung may explain the observation that the presence of P. aeruginosa in the sputum of patients with cystic fibrosis is correlated with the absence of S. aureus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1493979     DOI: 10.1093/jac/30.5.615

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  82 in total

1.  Pseudomonas aeruginosa inhibits the growth of Cryptococcus species.

Authors:  Antonella Rella; Mo Wei Yang; Jordon Gruber; Maria Teresa Montagna; Chiara Luberto; Yong-Mei Zhang; Maurizio Del Poeta
Journal:  Mycopathologia       Date:  2011-11-11       Impact factor: 2.574

2.  Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication.

Authors:  Eric Déziel; François Lépine; Sylvain Milot; Jianxin He; Michael N Mindrinos; Ronald G Tompkins; Laurence G Rahme
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

3.  Culturable endophytes of medicinal plants and the genetic basis for their bioactivity.

Authors:  Kristin I Miller; Chen Qing; Daniel Man-Yuen Sze; Basil D Roufogalis; Brett A Neilan
Journal:  Microb Ecol       Date:  2012-03-21       Impact factor: 4.552

4.  Albumin Inhibits Pseudomonas aeruginosa Quorum Sensing and Alters Polymicrobial Interactions.

Authors:  Allie Clinton Smith; Anne Rice; Bryan Sutton; Rebecca Gabrilska; Aimee K Wessel; Marvin Whiteley; Kendra P Rumbaugh
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

5.  A Genomic Approach To Identify Klebsiella pneumoniae and Acinetobacter baumannii Strains with Enhanced Competitive Fitness in the Lungs during Multistrain Pneumonia.

Authors:  Mallory J Agard; Egon A Ozer; Andrew R Morris; Raul Piseaux; Alan R Hauser
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

6.  The human innate immune protein calprotectin induces iron starvation responses in Pseudomonas aeruginosa.

Authors:  Emily M Zygiel; Cassandra E Nelson; Luke K Brewer; Amanda G Oglesby-Sherrouse; Elizabeth M Nolan
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

7.  Comparing the microbiota of the cystic fibrosis lung and human gut.

Authors:  Geraint B Rogers; Mary P Carroll; Lucas R Hoffman; Alan W Walker; David A Fine; Kenneth D Bruce
Journal:  Gut Microbes       Date:  2010-01-29

8.  Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum.

Authors:  Kelli L Palmer; Lindsay M Aye; Marvin Whiteley
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

9.  Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model.

Authors:  Laura M Filkins; Jyoti A Graber; Daniel G Olson; Emily L Dolben; Lee R Lynd; Sabin Bhuju; George A O'Toole
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

10.  Iron Depletion Enhances Production of Antimicrobials by Pseudomonas aeruginosa.

Authors:  Angela T Nguyen; Jace W Jones; Max A Ruge; Maureen A Kane; Amanda G Oglesby-Sherrouse
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.